{"id":232618,"date":"2026-03-05T10:15:05","date_gmt":"2026-03-05T16:15:05","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/03\/abstract-challenging-the-dogma"},"modified":"2026-03-05T10:15:05","modified_gmt":"2026-03-05T16:15:05","slug":"abstract-challenging-the-dogma","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/03\/abstract-challenging-the-dogma","title":{"rendered":"Abstract: Challenging the dogma\u2026"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/abstract94.jpg\"><\/a><\/p>\n<p>Here, Adrian Vella &amp; team show hepatic resistance to glucagon\u2019s effects on amino acid catabolism is not a significant factor in postprandial metabolism, regardless of obesity or hepatic steatosis: type2diabetes MASH Glucagon.<\/p>\n<hr>\n<p>Address correspondence to: Adrian Vella, Endocrine Research Unit, Mayo Clinic College of Medicine, 200 First St. SW, 5\u2013194 Joseph, Rochester, Minnesota 55,905, USA. Phone: 507.255.6515; Email: <a href=\"mailto:vella.adrian@mayo.edu\">vella.adrian@mayo.edu<\/a>.<\/p>\n<p>Find articles by Christie, H. in: <a target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=search&db=pubmed&term=Christie+H[au>&dispmax=50\"]PubMed<\/a> | <a target=\"_blank\" href=\"https:\/\/scholar.google.com\/scholar?q=%22author%3AH+Christie%22\">Google Scholar<\/a> | <a target=\"_blank\" href=\"https:\/\/orcid.org\/0000-0002-0606-6778\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"540\" class=\"aligncenter\" src=\"https:\/\/www.jci.org\/assets\/orcid_24x24-c3dd8466870e6d6844746d0390885a978817f110ed6b16957bc1ad3a282af054.png\"><\/a><\/p>\n<p><sup>1<\/sup>Division of Endocrinology, <i>Diabetes<\/i>, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Here, Adrian Vella &amp; team show hepatic resistance to glucagon\u2019s effects on amino acid catabolism is not a significant factor in postprandial metabolism, regardless of obesity or hepatic steatosis: type2diabetes MASH Glucagon. Address correspondence to: Adrian Vella, Endocrine Research Unit, Mayo Clinic College of Medicine, 200 First St. SW, 5\u2013194 Joseph, Rochester, Minnesota 55,905, USA. [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1512],"tags":[],"class_list":["post-232618","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-mobile-phones"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=232618"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232618\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=232618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=232618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=232618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}